IL17A and neoplasm: Furthermore, OC’s suppression of prostaglandin E2 (PGE2) disrupts Th17 plasticity by blocking cAMP-responsive element modulator (CREM)-α-mediated IL-17A transcription, thereby stabilizing Th1/Th17 ratios in favor of anti-tumor immunity [95].